Medical Infrared Thermal Imaging

Medical thermal imaging (MII) is becoming a common screening modality in the areas of neuromusculoskeletal injury, cancer, and circulatory pathology. As a physiological imaging modality that assesses body function, it can indicate developing disease states - and breast cancer - earlier than anatomical examinations. It is highly accurate and 100% safe, involving no radiation or contact. MII is helpful for chronic pain, disease processes, and monitoring treatment effectiveness on physiology. MII can also help to identify sources of pain, particularly those involving the neuromuscular and circulatory systems. And because every organ reflects itself on the skin surface, organ stress/compromise can be monitored. If disease processes are present, a thermal imager may detect them before symptoms become apparent, enabling early intervention and proactive treatment. The FDA approved the technology for adjunctive breast cancer screening in 1982, and it has been recognized as a viable diagnostic tool since 1987 by the AMA council on Scientific Affairs, the ACA Council on Diagnostic Imaging and the Congress of Neuro-Surgeons since 1988, and the American Academy of Physical Medicine and Rehabilitation since 1990. Research indicates that it is extremely effective in diagnosing most types of back, neck, and limb pain, especially latent or intractable types of pain syndromes. There are four ways in which MII services help physicians and their breast cancer patients: